Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-26

Clinical Trial Update: Pharmacokinetics Study of DESF in Adults With Oral Allergy Syndrome [Phase 2]

View source ↗

Summary

The Phase 2 pharmacokinetics study of DESF in adults with oral allergy syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DESF

Snippet

Sponsor: Aquestive Therapeutics | Conditions: Allergic Reaction | Phase 2 | Status: COMPLETED